BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10188858)

  • 1. Survival after radical treatment for transitional cell carcinoma of the bladder.
    Daehlin L; Haukaas S; Maartmann-Moe H; Medby PC
    Eur J Surg Oncol; 1999 Feb; 25(1):66-70. PubMed ID: 10188858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancer.
    Nieuwenhuijzen JA; Horenblas S; Meinhardt W; van Tinteren H; Moonen LM
    BJU Int; 2004 Oct; 94(6):793-7. PubMed ID: 15476510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
    Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
    J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era.
    Hautmann RE; Gschwend JE; de Petriconi RC; Kron M; Volkmer BG
    J Urol; 2006 Aug; 176(2):486-92; discussion 491-2. PubMed ID: 16813874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
    Granfors T; Tomic R; Ljungberg B
    Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
    Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK
    Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
    Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
    J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of pathologic stage T0 on organ-confined bladder transitional cell carcinoma following radical cystectomy.
    Cho KS; Seo JW; Park SY; Cho NH; Choi YD; Yang SC; Hong SJ
    Urol Int; 2008; 81(4):394-8. PubMed ID: 19077398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
    Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after cystectomy for invasive bladder cancer.
    de Vries RR; Nieuwenhuijzen JA; Vincent A; van Tinteren H; Horenblas S
    Eur J Surg Oncol; 2010 Mar; 36(3):292-7. PubMed ID: 20097512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter.
    Blank LE; Koedooder K; van Os R; van de Kar M; van der Veen JH; Koning CC
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):454-8. PubMed ID: 17560734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of the combination of external radiotherapy--partial cystectomy--interstitial brachytherapy in pT1 G3, pT2 and pT3 bladder tumors].
    Jordana F; Lagrange JL; Gérard JP; Amiel J
    Ann Urol (Paris); 2005 Nov; 39 Suppl 5():S104-12. PubMed ID: 16425727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical cystectomy in the elderly: Comparison of survival between younger and older patients.
    Clark PE; Stein JP; Groshen SG; Cai J; Miranda G; Lieskovsky G; Skinner DG
    Cancer; 2005 Feb; 103(3):546-52. PubMed ID: 15630702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?
    Denzinger S; Fritsche HM; Otto W; Blana A; Wieland WF; Burger M
    Eur Urol; 2008 Jan; 53(1):146-52. PubMed ID: 17624657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.